Client News
Filter by:
- Nov 2 2022 Profire Energy Reports Financial Results for Third Quarter Fiscal Year 2022
- Nov 2 2022 Processa Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2022 Results and Provide Drug Development Update on November 8, 2022 at 4:30 p.m. EST
- Oct 28 2022 Pingtan Marine Enterprise to Hold 2022 Annual General Meeting on December 14, 2022
- Oct 28 2022 Pingtan Marine Enterprise Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
- Oct 27 2022 Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
- Oct 25 2022 Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC
- Oct 21 2022 NetCents Technology Provides Cryptocurrency Merchant Gateway Technology Advancement Update
- Oct 21 2022 NeuBase Therapeutics Announces Gene Editing Research Agreement with Global Healthcare Company
- Oct 20 2022 Profire Energy Sets Third Quarter 2022 Conference Call for Thursday, November 3, 2022 at 8:30 a.m. ET
- Oct 14 2022 NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing